Find News

Filter articles

Showing 31 to 40 of 3906 results

AstraZeneca prevails in GSK royalties row at UK High Court

UK06-04-2023Legal developmentsMuireann Bolger

Feud involved a blockbuster cancer drug belonging to a family of PARP inhibitors | GSK unit failed to persuade the court of the merits of its ‘certain uses’ argument.

Pfizer faces infringement suit over COVID-19 vaccine

US06-04-2023Legal developmentsLiz Hockley

Arbutus and Genevant claims Pfizer/BioNTech vaccine uses patented technology | Claim follows last year’s lawsuit against Moderna.

Abbvie seeks to block copycat of endometriosis drug

US04-04-2023Liz Hockley

Lawsuit is second to be filed in Delaware over Abbvie’s Orilissa treatment | Abbive says Teva’s ANDA infringes patent granted in January.

GSK signs licence deals with three generics firms to make HIV preventative for low income countries

Africa, US30-03-2023Liz Hockley

The three companies will make low-cost versions of HIV PrEP drug | Generics will be available to consumers in 90 low- and middle-income countries.

New York judge awards $33m to Abbott in diabetes test strip dispute

US30-03-2023Liz Hockley

H&H Wholesale Services found to have committed ‘fraud on the court’ | Final amount includes attorneys’ fees and costs.

Notable IP partner joins Lathrop GPM

US28-03-2023Muireann Bolger

Recruit from DLA Piper brings two decades of patent and technical experience in life sciences, biotechnology, and healthcare industries.

EPO Enlarged Board of Appeal issues G 2/21 decision

EU28-03-2023Liz Hockley

Board provides guidance on evidence submitted after patent filing date | Eagerly awaited decision confirms what’s needed to prove a certain effect.

US refuses to compel lower prices for Pfizer and Astellas cancer drug

US23-03-2023Liz Hockley

NIH rejects petition to use “march-in” rights to allow cheaper competition | Xtandi is “widely available” to public, federal agency says.

Amarin launches Fed Circ bid to prove Hikma generic infringed heart drug

Japan, US23-03-2023Liz Hockley

Hikma label and public statements encouraged infringement, Amarin says | Delaware District Court had dismissed claims label was ‘not skinny enough’.

Exelixis takes Cipla to court over generic cancer drug

US21-03-2023Liz Hockley

Cipla claims Cabometyx patents are invalid | Exelixis wants generic blocked until at least 2030.

Showing 31 to 40 of 3906 results